L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast Cancer
- 16 January 1975
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 292 (3), 117-122
- https://doi.org/10.1056/nejm197501162920301
Abstract
Prolonged L-phenylalanine mustard (L-PAM) administration as an adjuvant to mastectomy in the management of patients with primary breast cancer and pathologically positive axillary nodes was evaluated by a prospective, randomized, clinical trial.This publication has 2 references indexed in Scilit:
- Surgical Adjuvant Chemotherapy in Cancer of the BreastAnnals of Surgery, 1968
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965